Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy.
The pathogenesis of accelerated cardiovascular damage commonly characterizing patients affected by systemic chronic inflammatory and autoimmune rheumatic disorders is quite complex and still not fully clarified. However, it is well accepted that a strong relationship between multiple factors, including both traditional cardiovascular risk factors and disease-related inflammatory and autoimmune mechanisms, may in part explain the precocious atherosclerotic vessel damage and the increased incidence of cardiovascular events. Nevertheless, although several recent studies focused their attention on the investigation of these complex mechanisms, data regarding possible preventive strategies aimed to reduce long-term cardiovascular risk in these subjects are still lacking and not conclusive. In this setting, the early introduction of evidence-based preventive measures for the correct management of patients with systemic autoimmune disorders would be of extreme importance to reduce subclinical atherosclerosis incidence and possible major cardiovascular events.
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Perugia, Via Enrico Dal Pozzo, 06122 Perugia, Italy.
Elena
E
Bartoloni
Alessia
A
Alunno
Onelia
O
Bistoni
Roberto
R
Gerli
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000150:complications*; D012306:Risk
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D018501:Antirheumatic Agents; D007004:Hypoglycemic Agents
Clin Rheumatol. 2009 Jun;28(6):705-10
19319624
Lupus. 2010 Jul;19(8):941-8
20581017
Int Immunopharmacol. 2006 Dec 5;6(12):1833-46
17052674
J Intern Med. 2010 Dec;268(6):578-85
20698926
Arthritis Rheum. 2004 Dec;50(12):3813-22
15593231
Rheum Dis Clin North Am. 2010 Feb;36(1):81-97, viii
20202592
Curr Rheumatol Rep. 2011 Feb;13(1):37-43
21061100
Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1282-9
19193937
J Rheumatol. 2010 Jun;37(6):1136-42
20436082
Circulation. 2005 Nov 22;112(21):3337-47
16301360
Clin Rheumatol. 2008 Mar;27(3):281-7
18066611
Curr Med Res Opin. 2008 Feb;24(2):469-80
18179735
Hypertension. 2010 Feb;55(2):333-8
20038753
Arthritis Care Res (Hoboken). 2011 Feb;63(2):178-83
20740611
Arthritis Care Res (Hoboken). 2010 Feb;62(2):258-65
20191526
Rheumatology (Oxford). 2010 Feb;49(2):295-307
19946022
Br J Clin Pharmacol. 2010 Jan;69(1):85-94
20078616
Expert Rev Clin Immunol. 2007 Jul;3(4):531-41
20477158
Semin Arthritis Rheum. 2008 Aug;38(1):13-9
18191989
Autoimmun Rev. 2009 Jul;8(8):663-7
19393192
Autoimmun Rev. 2010 Aug;9(10):701-7
20542146
Ann Rheum Dis. 2009 Sep;68(9):1395-400
18697775
J Rheumatol. 2011 Feb;38(2):236-41
21078723
Nat Rev Rheumatol. 2010 Mar;6(3):157-64
20142814
Arthritis Care Res (Hoboken). 2010 May;62(5):712-8
20191479
Ann Rheum Dis. 2009 Apr;68(4):546-51
18662929
Clin Biochem. 2010 May;43(7-8):661-5
20144599
Arthritis Rheum. 2005 Dec;52(12):3890-7
16320337
Ann N Y Acad Sci. 2009 Sep;1173:814-21
19758233
Ann Rheum Dis. 2006 Dec;65(12):1608-12
16793844
Ann Rheum Dis. 2008 Nov;67(11):1646-7
18854516
Rheumatology (Oxford). 2010 Jun;49(6):1076-81
20208070
J Rheumatol. 2010 Mar;37(3):521-8
20080919
Rheumatology (Oxford). 2008 Jul;47(7):1093-6
18511474
Arthritis Rheum. 2009 Aug;60(8):2428-37
19644959
Atherosclerosis. 2010 Mar;209(1):255-60
19781703
Ann Rheum Dis. 2010 Apr;69(4):683-8
19854705
Curr Opin Rheumatol. 2007 Mar;19(2):190-6
17278937
Ann N Y Acad Sci. 2010 Apr;1193:153-9
20398022
Arthritis Rheum. 2007 Sep;56(9):2905-12
17763428
Semin Arthritis Rheum. 2009 Apr;38(5):372-81
18395771
Arthritis Rheum. 2009 Oct;60(10):2861-9
19790058
Arthritis Rheum. 2010 Mar;62(3):863-8
20131232
Rheumatology (Oxford). 2006 Dec;45(12):1580-1; author reply 1581-2
17043043
Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1309-16
20828353
Ann Rheum Dis. 2009 Apr;68(4):460-9
19286905
Rheumatology (Oxford). 2009 Feb;48(2):113-8
19106168
Circulation. 2004 Jun 8;109(22):2744-8
15159291
J Rheumatol. 2009 Jun;36(6):1195-9
19447935
Best Pract Res Clin Rheumatol. 2005 Oct;19(5):823-38
16150405
Circulation. 2008 Apr 29;117(17):2262-9
18427133
J Immunol. 2009 Aug 15;183(4):2729-40
19620300
Arthritis Rheum. 2003 Jan;48(1):54-8
12528103
Arthritis Rheum. 2008 Jul;58(7):2105-12
18576352
Lancet. 2004 Jun 19;363(9426):2015-21
15207950
Open Cardiovasc Med J. 2010 Feb 23;4:89-96
20361002
J Rheumatol. 2009 Oct;36(10):2204-11
19723903
Arthritis Rheum. 2006 Sep;54(9):3060-1; author reply 3061
16948138
Vasc Health Risk Manag. 2008;4(3):605-14
18827910
Circ J. 2010 Feb;74(2):213-20
20065609
Ann Rheum Dis. 2010 Feb;69(2):325-31
19773290
Arthritis Rheum. 2009 Feb;60(2):631-2
19180496
Ann Rheum Dis. 2011 Jan;70(1):8-14
21109513
Autoimmun Rev. 2010 Oct;9(12):849-52
20692379
Arthritis Rheum. 2006 Feb;54(2):393-407
16447216